Kareem N Rayn, Graham R Hale, Gustavo Pena-La Grave, Piyush K Agarwal
{"title":"New therapies in nonmuscle invasive bladder cancer treatment.","authors":"Kareem N Rayn, Graham R Hale, Gustavo Pena-La Grave, Piyush K Agarwal","doi":"10.4103/iju.IJU_296_17","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Nonmuscle invasive bladder cancer (NMIBC) remains a very challenging disease to treat with high rates of recurrence and progression associated with current therapies. Recent technological and biological advances have led to the development of novel agents in NMIBC therapy.</p><p><strong>Methods: </strong>We reviewed existing literature as well as currently active and recently completed clinical trials in NMIBC by querying PubMed.gov and clinicaltrials.gov.</p><p><strong>Results: </strong>A wide variety of new therapies in NMIBC treatment are currently being developed, utilizing recent developments in the understanding of immune therapies and cancer biology.</p><p><strong>Conclusion: </strong>The ongoing efforts to develop new therapeutic approaches for NMIBC look very promising and are continuing to evolve.</p>","PeriodicalId":520644,"journal":{"name":"Indian journal of urology : IJU : journal of the Urological Society of India","volume":" ","pages":"11-19"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e5/4d/IJU-34-11.PMC5769243.pdf","citationCount":"36","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of urology : IJU : journal of the Urological Society of India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/iju.IJU_296_17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 36
Abstract
Introduction: Nonmuscle invasive bladder cancer (NMIBC) remains a very challenging disease to treat with high rates of recurrence and progression associated with current therapies. Recent technological and biological advances have led to the development of novel agents in NMIBC therapy.
Methods: We reviewed existing literature as well as currently active and recently completed clinical trials in NMIBC by querying PubMed.gov and clinicaltrials.gov.
Results: A wide variety of new therapies in NMIBC treatment are currently being developed, utilizing recent developments in the understanding of immune therapies and cancer biology.
Conclusion: The ongoing efforts to develop new therapeutic approaches for NMIBC look very promising and are continuing to evolve.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
